Previous Article | Next Article ![]()
Journal of Clinical Microbiology, March 1999, p. 709-714, Vol. 37, No. 3
Microbiology,1
Infectious Disease,2 and
Respiratory3 Services, Ciutat
Sanitària i Universitària de Bellvitge, L'Hospitalet
de Llobregat, Barcelona, Spain
Received 17 June 1998/Returned for modification 18 August
1998/Accepted 19 November 1998
In a large number of cases, the etiology of community-acquired
pneumonia (CAP) is not established. Some cases are probably caused by
Streptococcus pneumoniae. Transthoracic needle aspiration (TNA) culture has a limited sensitivity which might be improved by
antigen detection or gene amplification techniques. We evaluated the
capacity of a PCR assay and a latex agglutination test to detect
S. pneumoniae in samples obtained by TNA from 95 patients with moderate-to-severe CAP. Latex agglutination and PCR had
sensitivities of 52.2 and 91.3%, specificities of 88.7 and 83.3%,
positive predictive values of 62.3 and 65.6%, and negative predictive
values of 83.3 and 96.5%, respectively, when culture techniques were
used as the "gold standard." When we considered expanded criteria
for the diagnosis of pneumococcal pneumonia as a standard for our calculations, latex agglutination and PCR had sensitivities of 53.6 and
89.7%, specificities of 93.0 and 90.0%, positive predictive values of
78.9 and 81.3%, and negative predictive values of 80.3 and 94.7%,
respectively. The additional diagnosis provided by the PCR assay
compared to latex agglutination was 12.2% (95% confidence interval of
the difference from 0.4 to 20.1%). PCR was more sensitive than TNA
culture, particularly in patients who had received prior antibiotic
therapy (83.3 versus 33.3%). Although PCR is a very sensitive and
specific technique, it has not proved to be cost-effective in clinical
practice. Conversely, latex agglutination is a fast and simple method
whose results might have significant implications for initial
antibiotic therapy.
Community-acquired pneumonia (CAP)
continues to be a significant cause of morbidity and mortality
worldwide. Streptococcus pneumoniae is the most commonly
defined pathogen in nearly all studies of hospitalized adults (1,
8, 12). Current criteria for a definitive diagnosis of
pneumococcal pneumonia require the isolation of S. pneumoniae from blood, pleural fluid, a metastatic-site specimen,
or an uncontaminated respiratory sample obtained by invasive
techniques. In a substantial number of cases, despite recent
improvements in diagnostic methods, the etiology of CAP cannot be
established; some of these cases are probably caused by S. pneumoniae. Lately, transthoracic needle aspiration (TNA) has been
used to improve the diagnostic yield of pneumonia. In several studies,
TNA has proved to be safe and has provided an etiologic diagnosis in 30 to 60% of cases by standard microbiological methods (7, 17,
18). However, its diagnostic effectiveness can be reduced by a
number of factors, one of the most important of which is prior
antibiotic therapy. New techniques, such as antigen detection methods
and PCR, which do not depend on viable organisms, are probably less
affected by the administration of antimicrobial agents and might
improve the overall sensitivity of TNA (3, 6).
The aim of our study was to evaluate the ability of a PCR assay and a
latex agglutination test to detect S. pneumoniae in samples
obtained by TNA from patients with moderate-to-severe CAP.
Setting and population studied.
The study was conducted at
Bellvitge Hospital, a 1,000-bed university hospital in Barcelona,
Spain. From February 1995 through May 1997 all patients with
moderate-to-severe CAP requiring hospitalization were prospectively
monitored at our institution. They were seen by a member of the study
team who filled out a previously defined computer-assisted protocol and
who provided medical advice when required. TNA was regularly performed
at our institution during the study period because of the good results
in terms of safety and the experience of our pneumologists over the
last decade. During the study period, a total of 95 TNAs were performed
among the 533 patients admitted in our hospital. Therefore, use of the TNA was not the usual standard of care, and the final decision relied
on the emergency team attending each patient. For the purposes of this
study, we identified all patients with moderate-to-severe CAP from whom
TNA samples were obtained. TNA was performed if patients gave their
consent and were able to collaborate in the TNA procedure; it was not
performed in the presence of any of the following contraindications:
low platelet count ( TNA procedure.
Premedication with 0.5 mg of atropine was
administered intramuscularly 30 min before the puncture. Puncture was
performed without fluoroscopic or computed-tomography control, at the
patient's bedside, and before starting therapy. Intradermal and
subcutaneous anesthesia with mepivacaine was administered. The
procedure was carried out by using an ultrathin 25-gauge needle with
its stylet. When it was believed to be on the target, a 20-ml syringe
containing 5 ml of sterile saline was attached, and 4 ml was then
injected. Suction was applied vigorously for at least 30 s. A
second 20-ml syringe was then attached, and another 4 ml of saline was
injected. One of the syringes was randomly used for conventional
microbiological procedures and the latex agglutination test. The
remaining sample was stored at Microbiological studies.
Prior to the initiation of therapy,
two sets of blood cultures were drawn at the initial evaluation. Sputum
samples were processed for Gram stain and culture, when available.
Paired serum samples from the acute and convalescent phases (separated
by 3 to 8 weeks) were also obtained for serological studies.
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Usefulness of PCR and Antigen Latex Agglutination
Test with Samples Obtained by Transthoracic Needle Aspiration for
Diagnosis of Pneumococcal Pneumonia
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and methods
Results
Discussion
References
60,000 cells/ml), a quick ratio of >1.8 or a
quick time of <60%, severe pulmonary hypertension, mechanical
ventilation, AIDS, and uncontrollable cough.
72°C for later PCR determination.
For clinical reasons, if the amount of the TNA sample was insufficient,
priority was given to standard microbiological studies.
; Oxoid, Basingstoke, England). Detection of L. pneumophila serogroup 1 antigen in
urine was performed by an immunoenzymatic commercial kit (Legionella Urinary Antigen; Binax, Portland, Maine). Standard serological methods
in our laboratory were used for determining antibodies to the following
pathogens: Mycoplasma pneumoniae (indirect agglutination), Chlamydia psittaci (immunofluorescence [IF]),
Chlamydia pneumoniae (micro-IF), Coxiella
burnetii (IF), L. pneumophila serogroups 1 to 6 (enzyme
immunoassay [EIA]), respiratory syncytial virus (EIA), parainfluenza
3 virus (EIA), and influenza A virus (EIA).
Latex agglutination for pneumococcal antigen in TNA samples. After heating at 95°C for 5 min, TNA samples were centrifuged at 700 × g for 10 min. Agglutination was then performed on a 50-µl aliquot of the supernatant with the Slidex Pneumokit (bioMérieux, Marcy l'Etoile, France) according to the manufacturer's instructions. Reading of the tests was almost immediate.
PCR assay for S. pneumoniae. We used the method described by Zhang et al. (19), with minor modifications adapted to the specific conditions of our specimen. An 86 bp fragment of the PBP2b pneumococcal gene was amplified by this protocol. DNA extraction from TNA samples was accomplished with a commercial kit (QIAamp Blood Kit; Qiagen, Hilden, Germany) in order to avoid PCR inhibition by the hemoglobin frequently present in the specimen. The extraction procedure was completed after ca. 2 h of processing time.
Amplification was carried out in a PTC-100 thermal cycler (MJ Research, Inc., Watertown, Mass.) with primers JM01 (5'-ATG CAG TTG GCT CAG TAT GTA-3') and JM02 (5'-CAC CCA GTC CTC CCT TAT CA-3'), which were supplied by Cruachem, Glasgow, United Kingdom. The primers were diluted in water to reach a 100 µM stock solution. The final concentration in the reaction was 1 pmol/µl. PCR was performed in a 50-µl volume (25 µl of reagent mixture and 25 µl of template) containing 0.2 µl of Taq DNA polymerase (5 U/µl; Life Technologies, Gaithersburg, Md.); 5 µl of 10× buffer and 5 µl of 25 mM MgCl2 (both supplied with Taq enzyme); 5 µl of a mixture of digoxigenin-labeled deoxynucleoside triphosphates (PCR DIG Labeling Mix; Boehringer GmbH, Mannheim, Germany) containing 2 mM concentrations (each) of dATP, dCTP, and dGTP, 1.9 mM dTTP, and 0.1 mM dUTP; 0.25 µl of each stock solution primer; and 9.3 µl of bidistilled water. Amplification started with a denaturation step of 10 min at 94°C, followed by 30 cycles of 1 min at 94°C, 1 min at 55°C, and 1.5 min at 72°C. Finally, an additional extension cycle of 7 min at 72°C was carried out before proceeding to detection. The amplification step took about 4 to 5 h. Detection of PCR products was done by hybridization with a 5' biotinylated internal probe and by using an immunoenzymatic commercial method (PCR-ELISA DIG Detection; Boehringer) according to the manufacturer's instructions. The sequence for the probe was 5'-biotin-CAA ATA ATG GTG TTC GTG TGG CTC CTC GTA-3' (Cruachem, Glasgow, United Kingdom). A green color appeared after the enzymatic assay, which was read at 405 nm. This enzymatic detection took more than 4 hours. The complete PCR procedure was performed in duplicate for each sample. A positive control (DNA from a pneumococcal clinical isolate) and several negative controls (25 µl of bidistilled water) spotted between problem extracts were included in each run. A specimen was considered positive if its corresponding optical density was higher than twice the mean optical density value obtained for negative controls.Limit of detection of the PCR procedure. An overnight culture of a clinical strain of S. pneumoniae was suspended in a Mueller-Hinton broth to achieve a turbidity similar to that of the 0.5 McFarland standard. Then, serial 10-fold dilutions were made in the same broth supplemented with 5% human blood in order to mimic blood contamination in TNA samples. A 100-µl aliquot from each tube was plate subcultured before the remaining suspension was extracted by the same procedure as for TNA specimens and then amplified by PCR. Plates were incubated at 37°C for 24 h; the colonies were counted and referred to the exact number of CFU present in each tube suspension.
Definitions.
CAP was defined as a febrile, acute respiratory
illness with the presence of a new infiltrate evident on a chest
radiograph. Patients with a prior hospitalization within 2 weeks of a
current diagnosis of pneumonia were excluded. Hospitalization was
considered if one or more of the following conditions was present: age,
70 years; respiratory insufficiency (a PaO2 level of
60
mm Hg or a PaO2/FiO2 ratio of
300);
multilobar radiological involvement; shock; underlying diseases; and/or
unresponsiveness to previous antibiotic therapy. To calculate the
severity of the pneumonia we used the Simplified Acute Physiology Score
described elsewhere (9).
1/20) to
C. pneumoniae, (vi) the presence of IgA antibodies (
1/32) to C. pneumoniae, and (vii) seroconversion for the following
respiratory viruses: respiratory syncytial virus, parainfluenza 3 virus, and influenza A virus. Etiological diagnosis was considered
presumptive when a predominant microorganism that correlated with a
predominant morphotype in the Gram stain from an acceptable specimen
(presence of >25 polymorphonuclear leukocytes and <10 squamous cells
per low-magnification field [×10]) was isolated in sputum.
Presumptive aspiration pneumonia was diagnosed in the presence of a
suggestive clinical and radiological picture. Cases that did not
fulfill the etiologic diagnostic criteria described above were
considered "pneumonia of unknown etiology."
Besides these strict criteria, etiologic diagnosis was also obtained by
using expanded criteria. With the expanded criteria, cases either with
positive results for both latex agglutination test and PCR assay or
with a single positive PCR or latex agglutination test plus the
presence of gram-positive diplococci as the predominant morphotype in a
Gram stain from an acceptable-quality sputum sample could also be
considered to be pneumococcal pneumonia. Patients with positive results
based solely on PCR or on the latex agglutination test were considered
nonpneumococcal pneumonia cases (false positive for these assays).
Statistical methods. The final diagnosis of cases according to both the strict and the expanded criteria, as described above, was used as the standard for determining the diagnostic usefulness of the PCR and latex agglutination methods in terms of sensitivity, specificity, and positive and negative predictive values. For the purposes of the calculations, patients were classified into two groups: (i) those with pneumococcal pneumonia and (ii) those with nonpneumococcal pneumonia, including cases with other known causes and pneumonia of unknown etiology.
The hypothesis of equivalence between PCR and latex agglutination was tested by McNemar statistics with continuity correction or by the binomial test, as appropriate. The magnitude of the difference was calculated in exact limits, when appropriate. A P value of <0.05 was considered statistically significant.| |
RESULTS |
|---|
|
|
|---|
A total of 95 patients with moderate-to-severe CAP in whom TNA was performed were analyzed. There were 69 men and 26 women, with a mean age of 65 years (range, 19 to 87 years). The mean Simplified Acute Physiology Score was 8.7 (range, 1 to 27). In 34 patients, pneumonia involved more than one lobe on the initial chest radiograph evaluation. In 52 patients (54.7%) there were underlying diseases, mostly diabetes mellitus (n = 18), chronic heart diseases (n = 15), and chronic obstructive pulmonary disease (n = 13). In 18 patients there was more than one underlying disease. A total of 39 patients had received influenza vaccine, and only 2 patients had been immunized with pneumococcal vaccine in the previous 5 years. A total of 34 patients (37.8%) had received antibiotic treatment prior to hospital admission. Sputum samples were attempted from all study patients, but they were obtained only in 58 cases. In 28 of these the sample was considered an acceptable specimen for cultivation, as previously defined. A predominant microorganism was isolated in 14 cases, yielding S. pneumoniae in 9 cases and Haemophilus influenzae in 5 cases. In 3 additional cases in which the sputum sample was considered not acceptable for culture of conventional pathogens, a culture in selective media yielded L. pneumophila strains.
In 82 TNA samples, both the latex agglutination test and PCR assay were performed. In 3 of the total 95 specimens, there was not enough sample to perform both the latex agglutination test and the PCR (1 in the pneumococcal-pneumonia culture-positive group, 1 in the group with an etiology other than S. pneumoniae, and 1 in the unknown-etiology group). In three cases the sample amount was insufficient to perform PCR (one in the pneumococcal-pneumonia culture-positive group, two in the unknown-etiology group). Finally, in seven cases latex agglutination for pneumococcal antigen was not performed (one in the pneumococcal-pneumonia culture-positive group, one in the unknown-etiology group, and five in the other-etiologies group).
The TNA culture was positive in 29 cases (30.5%). S. pneumoniae was the most frequently isolated pathogen (16 cases), followed by L. pneumophila (9 cases), Haemophilus influenzae (2 cases), Escherichia coli (1 case), and mixed aerobic-anaerobic respiratory flora (1 case). In two cases, in addition to S. pneumoniae, a second pathogen (H. influenzae and Moraxella catarrhalis) was isolated in the TNA samples.
Overall, considering all standard techniques, 57 patients (60.0%) had an etiological diagnosis. TNA alone provided an etiological diagnosis in 10 cases (9 S. pneumoniae, 1 E. coli) and confirmed a presumptive diagnosis in 5 others (4 S. pneumoniae, 1 H. influenzae). Seven patients fulfilled strict diagnostic criteria for two different infectious agents.
Distributions of the final diagnosis and the PCR and latex
agglutination test results are shown in Tables
1 and 2. In
one case of M. pneumoniae pneumonia, the PCR determination
was inconclusive (borderline readings after repeated testing), and it
was considered true negative for the calculations.
|
|
The calculated limit of detection for our PCR assay was between 2 and
27 CFU/ml. As Table 3 shows, PCR was more
sensitive than latex agglutination. Focusing on the 82 samples in whom
both diagnostic tests were performed, the additional diagnosis provided by PCR assay was 32.7% (95% confidence interval of the difference from 9.5 to 36.4%) in the subgroup of culture-proven
pneumococcal-pneumonia group and 12.2% (95% confidence interval of
the difference from 0.4 to 20.1%) when calculated for all pneumonias.
Table 4 shows clinical and laboratory
data of false-positive results for either the PCR assay or the latex
agglutination test when the strict diagnostic criteria are used.
|
|
PCR was more sensitive than TNA culture, particularly in patients who
had received prior antibiotic therapy. Of the 34 patients who had
received antibiotic treatment prior to hospital admission, 6 fulfilled
the criteria for pneumococcal pneumonia. As shown in Table
5, TNA culture yielded S. pneumoniae in two cases (33.3%), while PCR was positive in five
cases (83.3%). For its part, latex agglutination was positive in one
of the four cases in which it was performed (25.0%).
|
The latex agglutination test result was available for physicians in the
emergency room in the majority of cases and provided information before
the initial antibiotic therapy was selected. In fact, only two patients
with a positive latex agglutination test were admitted on combined
-lactam and macrolide therapy. In none of the patients admitted on a
single
-lactam therapy was a macrolide added to therapy after a
negative latex agglutination result.
| |
DISCUSSION |
|---|
|
|
|---|
Although previous studies (7, 11, 17, 18) have shown TNA to be a highly specific technique for the diagnosis of pneumonia, current indications of TNA in the CAP setting have not been well defined. Our study did not address this issue. We studied a large number of hospitalized patients with moderate-to-severe CAP in whom TNA was performed and evaluated the effectiveness of the latex agglutination test and PCR in these specimens. As expected, TNA improved the diagnostic yield in our study; in fact, more than a quarter of the definitive etiologic diagnosis (15 of 57) were made by culture of TNA samples. As for our two false-negative PCR results, they were from non-bloody samples, and so a possible negative effect by hemoglobin was reasonably ruled out. However, the possibility of a negative test resulting from the use of separate syringes for doing the different microbiological studies should be born in mind.
It is assumed that culture-positive pneumococcal pneumonia represents only a portion of the cases of pneumonia caused by this pathogen, so there is considerable room for alternative, more-sensitive diagnostic tests. The new laboratory techniques used in the diagnosis of pneumococcal pneumonia mainly confront two challenges related to their sensitivity and specificity. The first is the lack of a satisfactory standard for comparison. This is especially true of methods based on gene amplification, which is assumed to have a very low limit of detection. The second is the increasing number of coinfections reported in several recent studies (2, 4, 10). This phenomenon may lead us to consider cases of undiagnosed coinfections as false-positive results of these techniques.
In addition to better sensitivity and good specificity, other important advantages of the new laboratory tests when applied on a routine basis are rapidity, simplicity, and cost-effectiveness. This is particularly the case when latex agglutination and PCR are compared for the diagnosis of pneumococcal pneumonia. Data from the literature have shown variable results from PCR assays with regard to sensitivity. In cases of bacteremic pneumococcal pneumonia, sensitivity with blood specimens has ranged from 37.5 to 100.0%, depending on the technical procedure used (5, 14, 16, 19). Overall, sensitivity is lower when PCR was applied to whole blood than when applied to buffy coat preparations or sera, probably as a consequence of the inhibitory effect of hemoglobin on the amplification. This could also partially explain why other authors have reported PCR assays to be less sensitive than pneumococcal antigen detection in TNA samples (13, 15).
In an attempt to avoid this negative effect and to increase sensitivitiy, we used a column DNA extraction method and amplicon detection by hybridization with a biotinylated probe. In our study, detection of pneumococcal DNA by PCR proved to be more sensitive than latex agglutination, although, when considering all patients, the difference was limited. In contrast, latex agglutination compares favorably with the PCR assay in terms of cost, simplicity, and rapidity. For instance, latex agglutination can be performed in less than half an hour of processing time. PCR assay, on the other hand, is labor-intensive; the complete procedure takes about 10 h, which precludes its use as a realistic alternative method to conventional diagnostic techniques.
There were three false-positive results in the latex agglutination test among patients with other known etiologies when the strict criteria were applied. In all three cases the patients had a final diagnosis of C. pneumoniae pneumonia. In one case, the clinical and laboratory data and the presence of gram-positive diplococci in a sputum Gram stain with growth of normal flora supported the assumption of a coinfection. This patient was considered as true positive in the analysis with expanded criteria. False-positive results of latex agglutination in patients with C. pneumoniae pneumonia have been reported elsewhere (15). It should be noted that we used serology as the standard diagnosis of C. pneumoniae infection; this is considered a sensitive technique, although its specificity in diagnosing acute infection is currently under debate.
As for PCR, there were also three false-positive results in patients with other known etiologies. One patient previously treated with amoxicillin had a serologically diagnosed C. pneumoniae pneumonia, so a possible coinfection cannot be excluded. The second patient presented with aspiration pneumonia in which mixed aerobic and anaerobic bacteria of the upper respiratory tract were isolated by TNA. There are two possible explanations for this result. First, the presence of multiple bacteria might have inhibited the growth of a small inoculum of S. pneumoniae which could be detected by gene amplification. Second, this might be a real false-positive result, given the relationship in the PBP-2b genes of viridans streptococci and S. pneumoniae, although Zhang et al. (19) found no such cross-reactivity with the same primers and probe as the ones we used in our PCR assay. E. coli pneumonia was diagnosed in the third patient because of TNA-positive culture for this microorganism and negative blood cultures (a sputum sample was not obtained). PCR test results were repeatedly positive for S. pneumoniae. Because the E. coli strain was not available for further studies, we considered this PCR result a false positive.
Clinical presentation of all patients with pneumonia of unknown etiology and positive results in PCR and/or latex agglutination tests was compatible with bacterial pneumonia, and it is our understanding that most of these cases are, in fact, caused by S. pneumoniae. In many cases etiologic diagnosis was not performed because of the impossibility of obtaining a sputum sample of good quality or because of other circumstances, such as previous antibiotic treatment. In fact, PCR was more sensitive than TNA culture and latex agglutination in this subgroup of patients. For these reasons, we considered the expanded criteria to be more suitable for evaluating the real performance of both PCR and latex agglutination assays.
In summary, our study shows that latex agglutination and PCR improve the diagnostic yield of TNA. Latex agglutination is a simple, inexpensive technique whose results can be made readily available in the emergency room setting. Although less sensitive than PCR, it appears to offer practical advantages for the choice of initial antibiotic therapy. PCR is a very sensitive and specific technique which, due to its complexity, should perhaps be reserved for research purposes. A sensitive and specific PCR assay such as the one we used here could be a good standard for future evaluations of other diagnostic techniques.
| |
ACKNOWLEDGMENTS |
|---|
This study was supported by a grant from the Fondo de Investigaciones Sanitarias de la Seguridad Social 95/1100.
B.R. is the recipient of Beca de la Ciutat Sanitària i Universitària de Bellvitge 1995, Beca de Ampliación de Estudios del Fondo de Investigaciones Sanitarias de la Seguridad Social 96/5163 and 97/5245, and Beca de la Fundació Universitària Agustí Pedro i Pons 1998.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Servicio de Microbiología, Hospital de Bellvitge "Prínceps d'Espanya," Feixa Llarga s/n, 08907 L'Hospitalet de Llobregat, Barcelona, Spain. Phone: 34-93-3357011, ext. 2642. Fax: 34-3-2607547. E-mail: josel.perez{at}csub.scs.es.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Bartlett, J. G., and L. M. Mundy.
1995.
Community acquired pneumonia.
New. Engl. J. Med.
333:1618-1624 |
| 2. |
Bates, J. H.,
G. D. Campbell,
A. L. Barron,
G. A. MacCraken,
P. N. Morgan,
E. B. Moses, and C. Davis.
1992.
Microbial etiology of acute pneumonia in hospitalized patients.
Chest
101:1005-1012 |
| 3. | Bella, F., J. Tort, M. A. Morera, J. Espaulella, and J. Armengol. 1993. Value of bacterial antigen detection in the diagnostic yield of transthoracic needle aspiration in severe community acquired pneumonia. Thorax 48:1227-1229[Abstract]. |
| 4. | Burman, L. Å., B. Trollfors, B. Angersson, J. Henrichsen, P. Juto, I. Kallings, T. Lagergård, R. Möllby, and R. Norrby. 1991. Diagnosis of pneumonia by cultures, bacterial and viral antigen detection tests, and serology with special reference to antibodies against pneumococcal antigens. J. Infect. Dis. 163:1087-1093[Medline]. |
| 5. |
Dagan, R.,
O. Shirker,
I. Hazan,
E. Leibovitz,
D. Greenberg,
F. Schlaeffer, and R. Levy.
1998.
Prospective study to determine clinical relevance of detection of pneumococcal DNA in sera of children by PCR.
J. Clin. Microbiol.
36:669-673 |
| 6. | Dorca, J., L. Esteban, T. Alonso, B. Barreiro, R. Verdaguer, and F. Manresa. 1993. Rapid diagnosis of pneumococcal pneumonia by latex agglutination and counterimmunoelectrophoresis in samples obtained by transthoracic needle aspiration. Am. Rev. Respir. Dis. 147:A653. |
| 7. | Dorca, J., F. Manresa, L. Esteban, B. Barreiro, E. Prats, J. Ariza, R. Verdaguer, and F. Gudiol. 1995. Efficacy, safety and therapeutic relevance of transthoracic aspiration with ultrathin needle in nonventilated nosocomial pneumonia. Am. J. Respir. Crit. Care Med. 151:1491-1496[Abstract]. |
| 8. | Fang, G. D., M. Fine, M. J. Oloff, D. Arisumi, V. L. Yu, W. Kapoor, T. Grayston, S. P. Wang, R. Kohler, R. R. Muder, Y. C. Yee, J. D. Rihs, and R. M. Vickers. 1990. New and emerging etiologies for community acquired pneumonia with implications for therapy: a prospective multicenter study of 359 cases. Medicine (Baltimore) 69:307-316[Medline]. |
| 9. | Le Gall, J. R., P. Loirat, A. Alpérovich, P. Glaser, C. Granthil, D. Mathieu, P. Mercier, R. Thomas, and D. Villers. 1984. A simplified acute physiology score for ICU patients. Crit. Care Med. 12:975-977[Medline]. |
| 10. | Lieberman, D., F. Schlaeffer, I. Boldur, D. Lieberman, S. Horowitz, M. G. Friedman, M. Leiononen, O. Horovitz, E. Manor, and A. Porath. 1996. Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one-year prospective study of 346 consecutive cases. Thorax 51:178-198. |
| 11. | Manresa, F., and J. Dorca. 1991. Needle aspiration techniques in the diagnosis of pneumonia. Thorax 46:601-603[Medline]. |
| 12. | Marrie, T. J., H. Durant, and L. Yates. 1989. Community acquired pneumonia requiring hospitalization: 5 year prospective study. Rev. Infect. Dis. 11:586-599[Medline]. |
| 13. |
Nogue , A.,
M. García,
C. Rivas,
A. Ruiz,
M. Falguera, and T. Puig.
1995.
Valoración de la especificidad en la detección del antígeno capsular de Streptococcus pneumoniae utilizando la reacción en cadena de la polimerasa como técnica de referencia.
Enferm. Infecc. Microbiol. Clin.
13:288-291[Medline].
|
| 14. |
Rudolph, K. M.,
A. J. Parkinson,
C. M. Black, and L. W. Mayer.
1993.
Evaluation of polymerase chain reaction for diagnosis of pneumococcal pneumonia.
J. Clin. Microbiol.
31:2661-2666 |
| 15. | Ruiz-González, A., A. Nogués, M. Falguera, J. M. Porcel, E. Huelin, and M. Rubio-Caballero. 1997. Rapid detection of pneumococcal antigen in lung aspirates: comparison with culture and PCR techniques. Respir. Med. 91:201-206[Medline]. |
| 16. | Salo, P., Å. Örtqvist, and M. Leinonen. 1995. Diagnosis of bacteremic pneumococcal pneumonia by amplification of pneumolysin gene fragment in serum. J. Infect. Dis. 171:479-482[Medline]. |
| 17. |
Torres, A.,
P. Jiménez,
J. Puig de la Bellacasa,
R. Cellis,
J. González, and J. Gea.
1990.
Diagnostic value of nonfluoroscopic percutaneous lung needle aspiration in patients with pneumonia.
Chest
98:840-844 |
| 18. |
Zalacaín, R.,
J. L. Llorente,
L. Gaztelurrutia,
J. I. Pijoan, and V. Sobradillo.
1995.
Influence of three factors on the diagnostic effectiveness of transthoracic needle aspiration in pneumonia.
Chest
107:96-100 |
| 19. | Zhang, Y., D. J. Isaacman, R. M. Wadowsky, J. Rydquist-White, J. C. Post, and G. D. Ehrlich. 1995. Detection of Streptococcus pneumoniae in whole blood by PCR. J. Clin. Microbiol. 33:596-601[Abstract]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|